盐皮质激素受体
药理学
化学
药品
受体
选择性
盐皮质激素
医学
生物化学
催化作用
作者
Anneli Nordqvist,Gavin O’Mahony,Maria Fridén‐Saxin,Marléne Fredenwall,Anders Hogner,Kenneth L. Granberg,Anna Aagaard,Stefan Bäckström,Anders Gunnarsson,Tim Kaminski,Yafeng Xue,Anita Dellsèn,Eva L. Hansson,Pia Hansson,Ida Ivarsson,Ulla Karlsson,Krister Bamberg,Majlis Hermansson,Jennie Georgsson,Bo Lindmark
出处
期刊:ChemMedChem
[Wiley]
日期:2016-11-29
卷期号:12 (1): 50-65
被引量:14
标识
DOI:10.1002/cmdc.201600529
摘要
Abstract The mineralocorticoid receptor (MR) is a nuclear hormone receptor involved in the regulation of body fluid and electrolyte homeostasis. In this study we explore selectivity triggers for a series of nonsteroidal MR antagonists to improve selectivity over other members of the oxosteroid receptor family. A biaryl sulfonamide compound was identified in a high‐throughput screening (HTS) campaign. The compound bound to MR with p K i =6.6, but displayed poor selectivity over the glucocorticoid receptor (GR) and the progesterone receptor (PR). Following X‐ray crystallography of MR in complex with the HTS hit, a compound library was designed that explored an induced‐fit hypothesis that required movement of the Met852 side chain. An improvement in MR selectivity of 11‐ to 79‐fold over PR and 23‐ to 234‐fold over GR was obtained. Given the U‐shaped binding conformation, macrocyclizations were explored, yielding a macrocycle that bound to MR with p K i =7.3. Two protein–ligand X‐ray structures were determined, confirming the hypothesized binding mode for the designed compounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI